FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2950002009> ?p ?o ?g. }

• W2950002009 endingPage "146" @default.
• W2950002009 startingPage "128" @default.
• W2950002009 abstract "Glioblastoma (GBM) is the most frequent and malignant brain tumor with a high mortality rate. The presence of a large population of macrophages (Mφ) in the tumor microenvironment is a prominent feature of GBM and these so-called tumor-associated Mφ (TAM) closely interact with the GBM cells to promote the survival, progression and therapy resistance of the GBM. Various therapeutic strategies have been devised either targeting the GBM cells or the TAM but few have addressed the cross-talks between the two cell populations. The present study was carried out to explore the possibility of exploiting the cross-talks between the GBM cells (GC) and TAM for modulation of the GBM microenvironment through using Nano-DOX, a drug composite based on nanodiamonds bearing doxorubicin. In the in vitro work on human cell models, Nano-DOX-loaded TAM were first shown to be viable and able to infiltrate three-dimensional GC spheroids and release cargo drug therein. GC were then demonstrated to encourage Nano-DOX-loaded TAM to unload Nano-DOX back into GC which consequently emitted damage-associated molecular patterns (DAMPs) that are powerful immunostimulatory agents as well as indicators of cell damage. Nano-DOX was next proven to be a more potent inducer of GC DAMPs emission than doxorubicin. As a result, Nano-DOX-damaged GC exhibited an enhanced ability to attract both TAM and Nano-DOX-loaded TAM. Most remarkably, Nano-DOX-damaged GC reprogrammed the TAM from a pro-GBM phenotype to an anti-GBM phenotype that suppressed GC growth. Finally, the in vivo relevance of the in vitro findings was tested in animal study. Mice bearing orthotopic human GBM xenografts were intravenously injected with Nano-DOX-loaded mouse TAM which were found releasing drug in the GBM xenografts 24 h after injection. GC damage was evidenced by the induction of DAMPs emission within the xenografts and a shift of TAM phenotype was detected as well. Taken together, our results demonstrate a novel way with therapeutic potential to harness the cross-talk between GBM cells and TAM for modulation of the tumor immune microenvironment." @default.
• W2950002009 created "2019-06-27" @default.
• W2950002009 creator A5005200461 @default.
• W2950002009 creator A5008505828 @default.
• W2950002009 creator A5009942771 @default.
• W2950002009 creator A5010819713 @default.
• W2950002009 creator A5017100408 @default.
• W2950002009 creator A5018580304 @default.
• W2950002009 creator A5035992866 @default.
• W2950002009 creator A5037754196 @default.
• W2950002009 creator A5045778333 @default.
• W2950002009 creator A5046191605 @default.
• W2950002009 creator A5055838753 @default.
• W2950002009 creator A5059510323 @default.
• W2950002009 creator A5068676227 @default.
• W2950002009 creator A5087128279 @default.
• W2950002009 date "2017-12-01" @default.
• W2950002009 modified "2023-10-14" @default.
• W2950002009 title "Harnessing the cross-talk between tumor cells and tumor-associated macrophages with a nano-drug for modulation of glioblastoma immune microenvironment" @default.
• W2950002009 cites W1714099931 @default.
• W2950002009 cites W1797263638 @default.
• W2950002009 cites W1874889006 @default.
• W2950002009 cites W1918028620 @default.
• W2950002009 cites W1965130745 @default.
• W2950002009 cites W1966720603 @default.
• W2950002009 cites W1980485314 @default.
• W2950002009 cites W1982027307 @default.
• W2950002009 cites W1982987783 @default.
• W2950002009 cites W1988692970 @default.
• W2950002009 cites W1997985212 @default.
• W2950002009 cites W2016612145 @default.
• W2950002009 cites W2028156849 @default.
• W2950002009 cites W2035833975 @default.
• W2950002009 cites W2040773741 @default.
• W2950002009 cites W2056696921 @default.
• W2950002009 cites W2064081167 @default.
• W2950002009 cites W2064456932 @default.
• W2950002009 cites W2067632426 @default.
• W2950002009 cites W2070855360 @default.
• W2950002009 cites W2073003731 @default.
• W2950002009 cites W2073586533 @default.
• W2950002009 cites W2076833412 @default.
• W2950002009 cites W2089573422 @default.
• W2950002009 cites W2094469836 @default.
• W2950002009 cites W2111895939 @default.
• W2950002009 cites W2115749410 @default.
• W2950002009 cites W2137823095 @default.
• W2950002009 cites W2140182328 @default.
• W2950002009 cites W2151335185 @default.
• W2950002009 cites W2159411337 @default.
• W2950002009 cites W2169550645 @default.
• W2950002009 cites W2220215167 @default.
• W2950002009 cites W2275318246 @default.
• W2950002009 cites W2331750420 @default.
• W2950002009 cites W2334484009 @default.
• W2950002009 cites W2405899780 @default.
• W2950002009 cites W2547855452 @default.
• W2950002009 cites W2580874098 @default.
• W2950002009 cites W2591531756 @default.
• W2950002009 cites W2595092778 @default.
• W2950002009 cites W2595863515 @default.
• W2950002009 cites W979102926 @default.
• W2950002009 doi "https://doi.org/10.1016/j.jconrel.2017.10.024" @default.
• W2950002009 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/29051064" @default.
• W2950002009 hasPublicationYear "2017" @default.
• W2950002009 type Work @default.
• W2950002009 sameAs 2950002009 @default.
• W2950002009 citedByCount "65" @default.
• W2950002009 countsByYear W29500020092018 @default.
• W2950002009 countsByYear W29500020092019 @default.
• W2950002009 countsByYear W29500020092020 @default.
• W2950002009 countsByYear W29500020092021 @default.
• W2950002009 countsByYear W29500020092022 @default.
• W2950002009 countsByYear W29500020092023 @default.
• W2950002009 crossrefType "journal-article" @default.
• W2950002009 hasAuthorship W2950002009A5005200461 @default.
• W2950002009 hasAuthorship W2950002009A5008505828 @default.
• W2950002009 hasAuthorship W2950002009A5009942771 @default.
• W2950002009 hasAuthorship W2950002009A5010819713 @default.
• W2950002009 hasAuthorship W2950002009A5017100408 @default.
• W2950002009 hasAuthorship W2950002009A5018580304 @default.
• W2950002009 hasAuthorship W2950002009A5035992866 @default.
• W2950002009 hasAuthorship W2950002009A5037754196 @default.
• W2950002009 hasAuthorship W2950002009A5045778333 @default.
• W2950002009 hasAuthorship W2950002009A5046191605 @default.
• W2950002009 hasAuthorship W2950002009A5055838753 @default.
• W2950002009 hasAuthorship W2950002009A5059510323 @default.
• W2950002009 hasAuthorship W2950002009A5068676227 @default.
• W2950002009 hasAuthorship W2950002009A5087128279 @default.
• W2950002009 hasBestOaLocation W29500020092 @default.
• W2950002009 hasConcept C126322002 @default.
• W2950002009 hasConcept C142724271 @default.
• W2950002009 hasConcept C185592680 @default.
• W2950002009 hasConcept C202751555 @default.
• W2950002009 hasConcept C203014093 @default.
• W2950002009 hasConcept C2776107976 @default.
• W2950002009 hasConcept C2776694085 @default.
• W2950002009 hasConcept C2778227246 @default.

• next